Drug-loaded PLGA nanoparticles for oral administration: fundamental issues and challenges ahead.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Critical reviews in therapeutic drug carrier systems

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1615/CRITREVTHERDRUGCARRIERSYST.V29.I2.20PMID 22475089
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen.

  2011cited by this paper
• PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.

  2011cited by this paper
• Pharmacokinetics and tissue distribution studies of orally administered nanoparticles encapsulated ethionamide used as potential drug delivery system in management of multi-drug resistant tuberculosis

  2011cited by this paper
• Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects.

  2010cited by this paper
• Toxicity assessment of nanomaterials: methods and challenges

  2010cited by this paper
• Interaction of biodegradable nanoparticles with intestinal cells: the effect of surface hydrophilicity.

  2010cited by this paper
• Endocytosis of nanomedicines.

  2010cited by this paper
• In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems.

  2010cited by this paper
• Nanoparticles: A personal experience for formulating poorly water soluble drugs.

  2010cited by this paper
• The suitability of different cellular in vitro immunotoxicity and genotoxicity methods for the analysis of nanoparticle-induced events

  2010cited by this paper
• Endocytosis and Intracellular Distribution of PLGA Particles in Endothelial Cells: Effect of Particle Geometry.

  2010cited by this paper
• Analytical methods to assess nanoparticle toxicity.

  2009cited by this paper
• Current in vitro methods in nanoparticle risk assessment: limitations and challenges.

  2009cited by this paper
• Polymeric carriers: preclinical safety and the regulatory implications for design and development of polymer therapeutics.

  2009cited by this paper
• Physical approaches to biomaterial design.

  2009cited by this paper
• Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size.

  2009cited by this paper
• PLGA Nanoparticles Stabilized with Cationic Surfactant: Safety Studies and Application in Oral Delivery of Paclitaxel to Treat Chemical-Induced Breast Cancer in Rat

  2009cited by this paper
• Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.

  2009cited by this paper
• Cryoprotectants for freeze drying of drug nano-suspensions: effect of freezing rate.

  2009cited by this paper
• In vitro assessments of nanomaterial toxicity.

  2009cited by this paper
• An innovative, quick and convenient labeling method for the investigation of pharmacological behavior and the metabolism of poly(DL-lactide-co-glycolide) nanospheres

  2009cited by this paper
• Design of Biodegradable Nanoparticles for Oral Delivery of Doxorubicin: In vivo Pharmacokinetics and Toxicity Studies in Rats

  2009cited by this paper
• Assessing the safety and cost-effectiveness of early nanodrugs.

  2009cited by this paper
• Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited.

  2009cited by this paper
• Seven challenges for nanomedicine.

  2008cited by this paper
• Microencapsulation by solvent evaporation: state of the art for process engineering approaches.

  2008cited by this paper
• Pharmacodynamic Evaluation of Oral Estradiol Nanoparticles in Estrogen Deficient (Ovariectomized) High-Fat Diet Induced Hyperlipidemic Rat Model

  2008cited by this paper
• Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique.

  2008cited by this paper
• Shape Induced Inhibition of Phagocytosis of Polymer Particles

  2008cited by this paper
• Intravascular Delivery of Particulate Systems: Does Geometry Really Matter?

  2008cited by this paper
• Oral Nanoparticulate Atorvastatin Calcium is More Efficient and Safe in Comparison to Lipicure® in Treating Hyperlipidemia

  2008cited by this paper
• Cellular uptake and cytotoxicity of silica nanotubes.

  2008cited by this paper
• Adsorption of essential micronutrients by carbon nanotubes and the implications for nanotoxicity testing.

  2008cited by this paper
• PLGA/PEG-derivative polymeric matrix for drug delivery system applications: Characterization and cell viability studies.

  2008cited by this paper
• Voriconazole into PLGA nanoparticles: improving agglomeration and antifungal efficacy.

  2008cited by this paper
• Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.

  2008cited by this paper
• The effect of particle design on cellular internalization pathways

  2008cited by this paper
• How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization?

  2008cited by this paper
• PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral.

  2007cited by this paper
• Development of Biodegradable Nanoparticles for Oral Delivery of Ellagic Acid and Evaluation of Their Antioxidant Efficacy Against Cyclosporine A-Induced Nephrotoxicity in Rats

  2007cited by this paper
• Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery.

  2007cited by this paper
• Nanoparticle-Based Oral Drug Delivery System for an Injectable Antibiotic – Streptomycin

  2007cited by this paper
• Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/therapy?

  2007cited by this paper
• Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers.

  2007cited by this paper
• Improved bioavailability of orally administered mifepristone from PLGA nanoparticles.

  2007cited by this paper
• Pharmaceutical nanotechnology: more than size. Ten topics for research.

  2007cited by this paper
• Characterization of nanoparticles for therapeutics.

  2007cited by this paper
• Bioaccessibility of arsenic(V) bound to ferrihydrite using a simulated gastrointestinal system.

  2006cited by this paper
• Oral nanoparticle-based antituberculosis drug delivery to the brain in an experimental model.

  2006cited by this paper
• Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage.

  2006cited by this paper
• Role of target geometry in phagocytosis.

  2006cited by this paper
• Dynasore, a cell-permeable inhibitor of dynamin.

  2006cited by this paper
• Freeze-drying of low molecular weight poly(L-lactic acid) nanoparticles: effect of cryo- and lyoprotectants.

  2006cited by this paper
• Sustained release nanoparticulate formulation containing antioxidant-ellagic acid as potential prophylaxis system for oral administration

  2006cited by this paper
• Critical freezing rate in freeze drying nanocrystal dispersions.

  2006cited by this paper
• Freeze-drying of nanoparticles: formulation, process and storage considerations.

  2006cited by this paper
• Design of Estradiol Loaded PLGA Nanoparticulate Formulations: A Potential Oral Delivery System for Hormone Therapy

  2006cited by this paper
• Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm.

  2006cited by this paper
• Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells

  2006cited by this paper
• POLYMERIC CORE‐SHELL NANOPARTICLES FOR THERAPEUTICS

  2006cited by this paper
• Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice.

  2005cited by this paper
• Clathrin- and caveolin-1–independent endocytosis

  2005cited by this paper
• Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.

  2005cited by this paper
• The Characteristics and Mechanisms of Uptake of PLGA Nanoparticles in Rabbit Conjunctival Epithelial Cell Layers

  2004cited by this paper
• PLGA nanoparticles in drug delivery: the state of the art.

  2004cited by this paper
• Hepatic uptake of negatively charged particles in rats: possible involvement of serum proteins in recognition by scavenger receptor.

  2004cited by this paper
• Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process.

  2004cited by this paper
• WGA-grafted PLGA-nanospheres: preparation and association with Caco-2 single cells.

  2004cited by this paper
• 3H Dendrimer Nanoparticle Organ/Tumor Distribution

  2004cited by this paper
• Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations.

  2004cited by this paper
• Oral delivery of spray dried PLGA/amifostine nanoparticles

  2004cited by this paper
• Mechanistic study of the uptake of wheat germ agglutinin-conjugated PLGA nanoparticles by A549 cells.

  2004cited by this paper
• The dawning era of polymer therapeutics

  2003cited by this paper
• Stabilisation by freeze-drying of cationically modified silica nanoparticles for gene delivery.

  2003cited by this paper
• Dynamics of Endocytosis and Exocytosis of Poly(D,L-Lactide-co-Glycolide) Nanoparticles in Vascular Smooth Muscle Cells

  2003cited by this paper
• Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol).

  2002cited by this paper
• Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration.

  2002cited by this paper
• In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres.

  2002cited by this paper
• Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake.

  2002cited by this paper
• An EU perspective on the use of in vitro methods in regulatory pharmaceutical toxicology.

  2002cited by this paper
• Important role of serum proteins associated on the surface of particles in their hepatic disposition.

  2002cited by this paper
• In Vitro and In Vivo Evaluation of Oral Heparin–Loaded Polymeric Nanoparticles in Rabbits

  2002cited by this paper
• Characterization of nanoparticle uptake by endothelial cells.

  2002cited by this paper
• Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease.

  2001cited by this paper
• Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers.

  2001cited by this paper
• Nanosphere based oral insulin delivery.

  2000cited by this paper
• Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs.

  2000cited by this paper
• Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.

  2000cited by this paper
• Arterial uptake of biodegradable nanoparticles: effect of surface modifications.

  1998cited by this paper
• Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers.

  1998cited by this paper
• Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches.

  1998cited by this paper
• The Oral Absorption of Micro- and Nanoparticulates: Neither Exceptional Nor Unusual

  1997cited by this paper
• A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model.

  1997cited by this paper
• Comparison of poly(DL-lactide-co-glycolide) and polystyrene microsphere targeting to intestinal M cells.

  1993cited by this paper
• Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency

  1990cited by this paper
• The determination of lactic dehydrogenase with a tetrazolium salt.

  1960cited by this paper

• A Thermosensitive Gel Containing Biodegradable Nanoparticles Carrying Calcium Hydroxide as Antibacterial Intracanal Therapy

  2025cites this paper
• Exploring the role of polymeric nanoparticles in transdermal delivery of natural bioactive molecules: an overview

  2025cites this paper
• PLGA Nanoparticles as New Drug Delivery Systems in Leishmaniasis Chemotherapy: A Review of Current Practices.

  2023cites this paper
• PLGA Particles in Immunotherapy

  2023cites this paper
• Zinc-Phthalocyanine Loaded PLGA-PVA-Chitosan Nanosystem for the Enhancement of Antidiabetic Activity.

  2023cites this paper
• Euphorbia tirucalli latex loaded polymer nanoparticles: Synthesis, characterization, in vitro release and in vivo antinociceptive action

  2022cites this paper
• Drug delivery systems for oral disease applications

  2022cites this paper
• Nano-pharmacokinetics: biodistribution and toxicology

  2021cites this paper
• Design of an amphiphilic hyperbranched core/shell-type polymeric nanocarrier platform for drug delivery

  2020cites this paper
• Effect of Chitosan Coating on PLGA Nanoparticles for Oral Delivery of Thymoquinone: In Vitro, Ex Vivo, and Cancer Cell Line Assessments

  2020cites this paper
• Rutin yüklü PLGA Nanopartiküller; Farklı Yöntemler Kullanılarak Sentezi ve Karakterizasyonu

  2019cites this paper
• Antileishmanial Activity of Amphotericin B-loaded-PLGA Nanoparticles: An Overview

  2018cites this paper
• Folate and Borneol Modified Bifunctional Nanoparticles for Enhanced Oral Absorption

  2018cites this paper
• On the Importance of Polyurethane and Polyurea Nanosystems for Future Drug Delivery.

  2018cites this paper
• Hydrolytic stability of polylactide stereocomplex microparticles containing metal ions

  2018cites this paper
• Factors relating to the biodistribution & clearance of nanoparticles & their effects on in vivo application.

  2018cites this paper
• Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles

  2017cites this paper
• Green Chemistry Oxidative Modification of Peptoids Utilizing Bleach and TEMPO

  2017cites this paper
• Development and advanced characterisation of antibiotic-loaded nanoparticles to fight intracellular bacteria

  2017cites this paper
• Development and characterisation of HPMC films containing PLA nanoparticles loaded with green tea extract for food packaging applications.

  2017cites this paper
• PLA micro- and nano-particles.

  2016influential citation
• Cell penetrating peptide-modified poly(lactic-co-glycolic acid) nanoparticles with enhanced cell internalization.

  2016cites this paper
• Inhaled dry powder formulations for treating tuberculosis.

  2015cites this paper
• Hybrid nanosystems based on natural polymers as protein carriers for respiratory delivery: Stability and toxicological evaluation.

  2015cites this paper
• Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy.

  2015cites this paper
• Capsaicin delivery into the skin with lipidic nanoparticles for the treatment of psoriasis

  2015cites this paper
• Hybrid nanosystems based on natural polymers as protein carriers for respiratory 1 delivery : Stability and toxicological evaluation 2

  2014cites this paper
• Protein Drug-Loaded Polymeric Nanoparticles

  2014cites this paper
• Emerging integrated nanohybrid drug delivery systems to facilitate the intravenous-to-oral switch in cancer chemotherapy.

  2014cites this paper
• Nanostructured liquid-crystalline particles for drug delivery

  2014cites this paper
• Pullulan-based nanoparticles as carriers for transmucosal protein delivery.

  2013cites this paper
• Tuberculosis and Nanotechnology: Where shall the Twain meet?

  2013cites this paper
• Cannabinoids delivery systems based on supramolecular inclusion complexes and polymeric nanocapsules for treatment of neuropathic pain

  2012cites this paper
• THESE DE L'UNIVERSITE DE LYON Délivrée par L'UNIVERSITE CLAUDE BERNARD LYON 1

  2010cites this paper